GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remedent Inc (OTCPK:REMI) » Definitions » Cyclically Adjusted PS Ratio

Remedent (Remedent) Cyclically Adjusted PS Ratio : (As of Apr. 28, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Remedent Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Remedent Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Remedent's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remedent Cyclically Adjusted PS Ratio Chart

Remedent Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Remedent Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Remedent's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Remedent's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remedent's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Remedent's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Remedent's Cyclically Adjusted PS Ratio falls into.



Remedent Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Remedent's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2020 is calculated as:

For example, Remedent's adjusted Revenue per Share data for the three months ended in Dec. 2020 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2020 (Change)*Current CPI (Dec. 2020)
=0.017/108.5107*108.5107
=0.017

Current CPI (Dec. 2020) = 108.5107.

Remedent Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201103 0.140 94.666 0.160
201106 0.150 95.508 0.170
201109 0.165 95.795 0.187
201112 0.105 96.360 0.118
201203 0.063 97.847 0.070
201206 0.021 97.659 0.023
201209 0.022 98.432 0.024
201212 0.036 98.511 0.040
201303 0.068 98.937 0.075
201306 0.035 99.215 0.038
201309 0.038 99.314 0.042
201312 0.043 99.462 0.047
201403 0.013 99.819 0.014
201406 0.046 99.482 0.050
201409 0.043 99.195 0.047
201412 0.042 99.086 0.046
201503 0.049 99.423 0.053
201506 0.041 100.107 0.044
201509 0.035 100.245 0.038
201512 0.033 100.572 0.036
201603 0.029 101.653 0.031
201606 0.031 102.267 0.033
201609 0.031 102.118 0.033
201612 0.030 102.614 0.032
201703 0.027 103.972 0.028
201706 0.040 103.902 0.042
201709 0.034 104.170 0.035
201712 0.037 104.804 0.038
201803 0.024 105.419 0.025
201806 0.022 106.063 0.023
201809 0.017 106.618 0.017
201812 0.021 107.252 0.021
201903 0.020 107.876 0.020
201906 0.016 107.896 0.016
201909 0.012 107.470 0.012
201912 0.013 108.065 0.013
202003 0.013 108.550 0.013
202006 0.011 108.540 0.011
202009 0.016 108.441 0.016
202012 0.017 108.511 0.017

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Remedent  (OTCPK:REMI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Remedent Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Remedent's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Remedent (Remedent) Business Description

Traded in Other Exchanges
N/A
Address
Zuiderlaan 1-3, Box 8, Ghent, BEL, 9000
Remedent Inc is a manufacturer of cosmetic dentistry products in Europe. The company is engaged in the research, development, and manufacturing of oral care and cosmetic dentistry products. It designs, develops, manufactures, and distributes cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, the Middle East, and the United States. The product line of the company includes SmileWise, the SmileMe mirror, and the Condor intra-oral 3D scanner.
Executives
Stuart Steinberg 10 percent owner 85 BELLEVUE AVENUE, RYE NY 10580
Marxe Austin W & Greenhouse David M 10 percent owner C/O SPECIAL SITUATIONS FUNDS, 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Gruber & Mcbaine Capital Management Llc 10 percent owner 234 VAN NESS, STE 5, SAN FRANCISCO CA 94133
Stephen Farley Ross director, officer: CFO; Secretary XAVIER DE COCKLAAN 42 DEURLE C9 9831
Fred Kolsteeg director XAVIER DE COCKLAAN 42 DEURLE C9 9831
Acker Philippe Van director C/O REMEDENT, INC. XAVIER DE COCKLAAN 42 9831 DEURLE C9 9831
Robin List other: Former Officer and Director XAVIER DE COCKLAAN 42 DEURLE C9 9831
Roger Leddington officer: Sr VP & Head of US Marketing C/O REMEDENT, INC. XAVIER DE COCKLAAN 42 DEURLE C9 9831
Guy Devreese director, officer: Chairman of the Board XAVIER DE COCKLAAN 42 DEURLE C9 9831
Judd Darrin Hoffman officer: VP Worldwide Sales/Operations 702A JUANITA AVENUE REDONDO BEACH CA 90277
Nv Lausha 10 percent owner C/O REMEDENT, INC. XAVIER DE COCKLAAN 42 9831 DEURLE C9 9831

Remedent (Remedent) Headlines

From GuruFocus

Making Money from Smiles

By Frank Lind Frank Lind 05-26-2011